Actuarial Health Insights - June 2014
This edition of Health Actuarial Insights captures information on End of open enrollment: the current exchange landscape, Healthcare reform and medicaid, Thinking strategically about IBNR and NAIC Update regarding long-term care.
Healthcare & Life Sciences Institute Tue, 12 Aug 2014 00:00:00 GMT
What is Cost Transparency in Healthcare?
This KPMG Global Healthcare Center of Excellence Issue Brief summarizes the current state of cost transparency efforts and considerations that health plans need to make in providing cost transparency tools to the consumer.
Healthcare & Life Sciences Institute Sun, 01 Jan 2017 00:00:00 GMT
Business Transformation and the Regulatory Environment
The current dynamic regulatory environment is a very important trigger of transformation. Depending on the industry sector, the regulatory environment can be a partial or dominant trigger for transformation. In this paper, we outline three different approaches that companies currently employ,...
Healthcare & Life Sciences Institute Mon, 01 Sep 2014 00:00:00 GMT
Revenue Cycle 3.0 - Harnessing the power of process analytics and automated workflow
These are not easy times for financial operations at many U.S. healthcare organizations. On the one hand, margins are getting squeezed and at the same time, most organizations are now also expecting an increase in overall activity and a decrease in reimbursement.
Healthcare & Life Sciences Institute Thu, 21 Aug 2014 00:00:00 GMT
The Post Base Erosion and Profit Shifting World
This report is intended as a factual description of the issues arising as a result of the complexities of the international tax systems and their impact on life sciences businesses.
Healthcare & Life Sciences Institute Wed, 01 Oct 2014 00:00:00 GMT
Deep Dive into Data - An aggregate spend compliance assessment that works
A deep dive assessment can uncover inconsistencies between reported information and source systems, highlight inaccuracies in master data, and identify issues that arise during reconciliation of all data to the general ledger (G/L) and other systems.
Healthcare & Life Sciences Institute Sun, 07 Dec 2014 00:00:00 GMT
Unlocking Value Growth in the Biopharmaceutical Market
Delivering “winning” performance in today’s biopharmaceutical landscape requires making the right therapeutic area, geography, and physician/hospital participation choices as well as determining how to deliver more stakeholder benefit than the competition, while getting paid for it.
Healthcare & Life Sciences Institute Tue, 25 Nov 2014 00:00:00 GMT
Medicare Advantage Survey Brief
KPMG and Strategic Health Partners conducted a study on Medicare Advantage Strategies to identify: what consumer behaviors health plans should consider as they structure and market MA plans; how pharmaceutical companies can influence consumer pharmacy preferences; and the advantages for...
Healthcare & Life Sciences Institute Mon, 24 Nov 2014 00:00:00 GMT
What Works: Staying Power - Success Stories in Global Healthcare
Key insights from KPMG’s global healthcare conference of 65 healthcare leaders from 30 countries engaged in peer-to-peer discussions on effective strategies for successful healthcare transformation.
Healthcare & Life Sciences Institute Fri, 05 Dec 2014 00:00:00 GMT
Developing an Adaptable and Sustainable All Payer Database (APD)
This white paper addresses the why, what, and how of All Payer Database (APDs) and provides our perspectives on next steps for states to consider in moving to an APD solution.
Healthcare & Life Sciences Institute Mon, 26 Jan 2015 00:00:00 GMT
Medical Affairs Under the Microscope
With corporate integrity agreements (CIAs) broadening in scope and strong pressure from federal regulators to create clearer separation between commercial and medical activities, many life sciences organizations are starting to take a closer look at the structure, processes, and controls...
Healthcare & Life Sciences Institute Mon, 12 Jan 2015 00:00:00 GMT
Improving the Value of Divestitures - 10 tips for the Life Sciences sector
Based on our experience working with pharmaceutical companies, medical device manufacturers, healthcare technology providers, and clinical research organizations, we see 10 key areas where life sciences organizations will need to focus if they hope to enhance value through divestitures.
Healthcare & Life Sciences Institute Mon, 15 Dec 2014 00:00:00 GMT
Planning For Meaningful Use Stage 2
Preparing for Stage 2 attestation requires careful planning and collaboration, which can be accomplished while waiting for your Certified Electronic Health Record Technology (CEHRT) updates. Throughout this white paper, you will see planning and preparation steps that are essential to achieving...
Healthcare & Life Sciences Institute Thu, 15 Jan 2015 00:00:00 GMT
Medicare Advantage Insights Study
The hypothesis that Medicare Advantage could be an important driver in the evolving value-based healthcare system led KPMG to work with Strategic Health Perspectives to initiate the Medicare Advantage Strategies Study. The research included a quantitative survey of 175 US residents aged 64+ who...
Healthcare & Life Sciences Institute Wed, 21 Jan 2015 00:00:00 GMT
Seeing beyond the Numbers: Improving revenue cycle results through data visualization
The value of data has dramatically increased as new analytic capabilities emerge to take advantage of the various data sources that have become available.
Healthcare & Life Sciences Institute Thu, 05 Feb 2015 00:00:00 GMT